MRKR Chart
See on advanced chart >
About
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology...
Read More
- HighlightA clinical-stage immuno-oncology company that develops next-generation T cell-based immunotherapies for hematological malignancies and solid tumor indications
- ExchangeNASDAQ
- Listing Date11/08/2016
- Established DateInvalid Date
- Full-time Employees67
- Address3200 Southwest Freeway Suite 2500 Houston Texas 77027
- Tel1-713-4006400
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
